欢迎来到《四川大学学报(医学版)》
张驰, 黄静, 杨萍, 等. 鸢尾素通过调控NF-κB通路减轻糖尿病心肌病炎症反应[J]. 四川大学学报(医学版), 2023, 54(3): 545-551. DOI: 10.12182/20230560111
引用本文: 张驰, 黄静, 杨萍, 等. 鸢尾素通过调控NF-κB通路减轻糖尿病心肌病炎症反应[J]. 四川大学学报(医学版), 2023, 54(3): 545-551. DOI: 10.12182/20230560111
ZHANG Chi, HUANG Jing, YANG Ping, et al. Irisin Alleviates Inflammatory Injury in Diabetic Cardiomyopathy by Regulating NF-κB Pathway[J]. Journal of Sichuan University (Medical Sciences), 2023, 54(3): 545-551. DOI: 10.12182/20230560111
Citation: ZHANG Chi, HUANG Jing, YANG Ping, et al. Irisin Alleviates Inflammatory Injury in Diabetic Cardiomyopathy by Regulating NF-κB Pathway[J]. Journal of Sichuan University (Medical Sciences), 2023, 54(3): 545-551. DOI: 10.12182/20230560111

鸢尾素通过调控NF-κB通路减轻糖尿病心肌病炎症反应

Irisin Alleviates Inflammatory Injury in Diabetic Cardiomyopathy by Regulating NF-κB Pathway

  • 摘要:
      目的  探究鸢尾素(irisin)在糖尿病心肌病(diabetic cardiomyopathy, DCM)中的保护作用及其机制。
      方法  高脂饮食联合链脲佐菌素建立DCM小鼠模型,动物实验设置对照组,DCM组,DCM+低、高剂量irisin组以及DCM+吡咯烷二硫代氨基甲酸(pyrrolidine dithiocarbamate, PDTC)〔核因子(nuclear factor, NF)-κB抑制剂 〕组,成功建模后irisin干预3周。采用HE、Masson染色观察心肌形态学改变;全自动生化分析仪检测血清肌酸激酶(creatine kinase, CK)和肌酸激酶同工酶(creatine kinase isoenzyme, CK-MB)水平。将H9c2细胞分为对照组、高糖/高脂(HG/HL)组、HG/HL+低剂量irisin组、HG/HL+高剂量irisin组以及HG/HL+PDTC组,CCK-8法检测细胞活力。ELISA测定心肌组织和细胞肿瘤坏死因子-α(tumor necrosis factor-α, TNF-α)、白细胞介素(interleukin, IL)-1β和IL-6表达水平;Western blot检测心肌组织和细胞中NF-κB p65蛋白核转移情况以及核因子κB抑制蛋白α(nuclear factor-κB inhibitor protein α, IκBα)表达水平。
      结果  动物实验结果显示,低、高剂量irisin能不同程度减轻心肌组织病理损伤与纤维化,抑制CK、CK-MB和炎症因子水平,上调IκBα蛋白表达,抑制NF-κB p65核转移;细胞实验结果显示,低、高剂量irisin能不同程度增强H9c2细胞活力,上调IκBα蛋白水平,抑制NF-κB p65核转移和炎症因子水平。DCM+低、高剂量irisin组的上述变化与DCM+PDTC组相似。
      结论   irisin可能通过抑制NF-κB p65核转移,减轻DCM小鼠心肌组织和高糖高脂诱导H9c2心肌损伤细胞中的炎症反应,发挥心肌保护作用。

     

    Abstract:
      Objective  To investigate the protective effect of irisin in diabetic cardiomyopathy (DCM) and its mechanism.
      Methods  A mouse model of DCM was established by high-fat diet combined with the injection of streptozotocin. The mice were assigned to a control group, a DCM group, a DCM+low-dose irisin group, a DCM+high-dose irisin group, and a DCM+pyrrolidine dithiocarbamate (PDTC) (nuclear factor NF-κB inhibitor) group. Then, the mice received irisin intervention for 3 weeks after successful modeling. Myocardial morphologic changes were observed by hematoxylin and eosin (HE) staining and Masson staining. The levels of serum creatine kinase (CK) and creatine kinase isoenzyme CK-MB were examined by automatic biochemical analyzer. H9c2 cells were divided into the control group, high glucose and high lipid (HG/HL) group, HG/HL+low-dose irisin group, HG/HL+high-dose irisin group, and HG/HL+PDTC group. CCK-8 assay was conducted to determine cell viability. The expression levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 in the myocardial tissue and the cells were determined by ELISA. In addition, nuclear translocation of NF-κB p65 protein and the protein expression level of NF-κB inhibitor protein α (IκBα) in the myocardial tissue and the cells were determined by Western blot.
      Results  According to the results of animal experiment, low and high doses of irisin could alleviate the pathological injury and fibrosis of myocardial tissue to varying degrees. Irisin inhibited the levels of CK, CK-MB, and inflammatory factors, up-regulated IκB protein expression, and diminished NF-κB nuclear translocation. According to the results of cell experiment, low and high doses of irisin could enhance H9c2 cell viability to varying degrees, increase the level of intracellular IκB proteins, and inhibit NF-κB p65 nuclear translocation and inflammatory factor expression. The changes in these aspects in the DCM+low-dose irisin group and the DCM+high-dose irisin group were similar to those in the DCM+PDTC group.
      Conclusion  Through inhibiting NF-κB p65 nuclear translocation, irisin may reduce the inflammatory response in the myocardial tissue of DCM mice and H9c2 cells of myocardial injury induced by high glucose and high fat, thereby exerting a protective effect on myocardium.

     

© 2023 《四川大学学报(医学版)》编辑部 版权所有 cc

开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问 https://creativecommons.org/licenses/by-nc/4.0

/

返回文章
返回